Event details from: Legal and policy challenges to pharmaceutical regulation

Date
9 January 2024
Time
09:30 – 13:00
Room
A3.01

This seminar brings together ongoing or recently completed research on legal and policy aspects of regulatory decision making that are relevant for multiple jurisdictions. It is part of the NWO veni project Global Access to Medicines through EU Law & Policy.

Registration (free of charge) is required for this in-person event.

Programme

9:30 Round of introductions

Patient stories in regulatory decision making

Dr. Tineke Kleinhout-Vliek, Utrecht University

Representing patient interests in public policy: Is industry funding a concern?

Prof. Barbara Mintzes PhD, University of Sydney

Lex Sex – Regulatory perspectives on women in clinical trials

Dr. Jakob Wested, University of Copenhagen/Danish Medicines Agency

10:45-11:00 Break

EMA and FDA use of Real World Data: comparing the data and definitions

Kaat van Delm LLM, KU Leuven

Are innovative medicines authorized by the EU also approved in developing countries?

Dr. Katrina Perehudoff and Majd Alshoufi BPharm MSc, University of Amsterdam

External trust in the EMA: Implications for access to vaccines in Least Developed Countries

Pramiti Parwani LLM, University of Amsterdam

Patient safety in low- and middle-income countries: the role of EMA advice to withdraw medicines

Séraphine Bruinsma BSc, Vrije Universiteit Amsterdam

12:00-13:00 Lunch (provided)